NCT00710242 - Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor | Biotech Hunter

Enrollment

263

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions

PregnancyLabor

Interventions

DRUG

DF01

Once daily s.c. injections from approximately 3-7 days before expected delivery (maximum 2 weeks before) until delivery (maximum 2 weeks after expected delivery)

DRUG

Placebo

Once daily s.c. injections from approximately 3-7 days before expected delivery (maximum 2 weeks before) until delivery (maximum 2 weeks after expected delivery)

Trial Locations (18)

SE-501 82

Kvinnokliniken Alvsborgs sjukhus Boras, Borås

Unknown

Gavle sjukhus, Gävle

Sahlgrenska/Ostra sjukhuset, Gothenburg

Karolinska Universistetssjuhuset, Huddinge

Lanssjukhuset Ryhov, Jönköping

Lanssjukhuset, Kalmar

Universitetssjukhuset, Linköping

Universitetssjukhuset, Lund

Vrinnevisjukhuset, Norrköping

Nyköpings lasarett, Nyköping

Universitetssjukhuset, Örebro

Kärnsjukhuset, Skövde

Danderyds sjukhus, Stockholm

Sodersjukhuset, Stockholm

Norra Älvsborgs länssjukhus, Trollhättan

Akademiska sjukhuset, Uppsala

Centrallasarettet, Vaxjo

Centrallasarettet, Västerås